Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.20    5.90 (3.01%)
Bid:
202.00
Ask:
202.80
Spread: 0.80 (0.396%)
Market Cap: £1.31b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Stabilisation Notice

12 Oct 2006 07:00

Ashmore Group PLC 12 October 2006 12 October 2006 Stabilisation Notice: Ashmore Group plc In connection with the Placing in relation to the following ordinary shares: Ashmore Group plc ordinary shares of 0.01p each ISIN Code: GB00B132NW22 UBS Limited as stabilisation manager, or any other person acting for it may, over-allot and effect other transactions with a view to supporting the market price of the ordinary shares at a level higher than that which might otherwise prevail from 8:00a.m. on 12 October 2006 to 10 November 2006. However, there may be no obligation on UBS Limited, or any agent of UBS Limited, to do this. Such transactions may be effected on the London Stock Exchange and any other securities market, over the counter market, stock exchange or otherwise. Such stabilising, if commenced, may be discontinued at any time and must be brought to an end no later than 10 November 2006. In connection with its stabilising activities Mark Coombs and Jon Moulton have granted UBS Limited, on behalf of the Underwriters, an over-allotment option, utilisable on or before 10 November 2006 which, if utilised will require Mark Coombs and Jon Moulton to sell up to 10 per cent. of the aggregate number of ordinary shares available in the Placing (before any exercise of the Over-allotment Option) at the Placing Price to cover short positions arising from such over-allotments (if any) and/or sales of ordinary shares effected by it during the stabilising period. UBS Limited has agreed with Ashmore Group plc that any over-allotment of ordinary shares by it or any of its agents will be up to a maximum of 10 per cent. of the total number of ordinary shares comprised in the Placing (before any exercise of the Over-allotment Option). Number of ordinary shares in the Placing: 177,266,000 Number of ordinary shares subject to the Over-allotment Option: 17,726,600 The Placing Price of Ashmore Group plc ordinary shares of 0.01p each was set at 170p per ordinary share on 12 October 2006. UBS Limited contacts: Adam Welham +44 207 568 6342 This announcement may not be distributed, directly or indirectly, in or into the United States, Canada, Australia or Japan. This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of Ashmore Group plc in any jurisdiction. In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the 'Prospectus Directive') before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the Placing are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State. The Placing and the distribution of this announcement and other information in connection with the Placing in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States. Defined terms used in this announcement have the same meaning as in the Company's Prospectus dated 12 October 2006 unless the context requires otherwise Stabilisation/FSA END
Date   Source Headline
8th Nov 20224:20 pmRNSHolding(s) in Company
28th Oct 202210:13 amRNSHolding(s) in Company
14th Oct 20222:11 pmRNSResult of AGM
14th Oct 20227:00 amRNSTrading Statement
5th Oct 20226:03 pmRNSHolding(s) in Company
23rd Sep 20224:56 pmRNSDirector/PDMR Shareholding
15th Sep 202210:36 amRNSDirector/PDMR Shareholding
14th Sep 20226:00 pmRNSHolding(s) in Company
9th Sep 20225:19 pmRNSNotice of AGM
2nd Sep 20227:00 amRNSFinal Results
22nd Jul 202211:33 amRNSDirectorate Change
14th Jul 20227:00 amRNSTrading Statement
25th Apr 20227:00 amRNSHolding(s) in Company
14th Apr 20227:00 amRNSTrading Statement
1st Apr 20223:02 pmRNSDirector/PDMR Shareholding
21st Mar 20224:30 pmRNSDirectorate Change
17th Mar 202211:35 amRNSDirector/PDMR Shareholding
17th Jan 20227:00 amRNSTrading Statement
13th Dec 202111:34 amRNSDirector/PDMR Shareholding
15th Oct 20213:42 pmRNSResult of AGM
14th Oct 20217:00 amRNSTrading Statement
23rd Sep 202112:27 pmRNSDirector/PDMR Shareholding
23rd Sep 202112:24 pmRNSDirector/PDMR Shareholding
17th Sep 20219:52 amRNSDirector/PDMR Shareholding
17th Sep 20219:48 amRNSDirector/PDMR Shareholding
10th Sep 20214:00 pmRNSNotice of AGM
3rd Sep 20217:00 amRNSFinal Results
14th Jul 20217:00 amRNSTrading Statement
30th Apr 20212:51 pmRNSDirector/PDMR Shareholding
23rd Apr 20213:12 pmRNSDirectorate Change
16th Apr 20217:00 amRNSTrading Statement
13th Apr 20213:45 pmRNSAGM voting result update statement
6th Apr 20212:54 pmRNSDirector/PDMR Shareholding
6th Apr 20212:37 pmRNSDirector/PDMR Shareholding
18th Mar 20216:02 pmRNSDirector/PDMR Shareholding
16th Feb 20214:35 pmRNSHolding(s) in Company
16th Feb 20214:29 pmRNSDirector/PDMR Shareholding
10th Feb 20217:00 amRNSHalf-year Report
15th Jan 20217:00 amRNSTrading Statement
11th Dec 20205:40 pmRNSDirector/PDMR Shareholding
11th Dec 20205:37 pmRNSDirector/PDMR Shareholding
19th Oct 20206:20 pmRNSHolding(s) in Company
19th Oct 20205:47 pmRNSDirector/PDMR Shareholding
16th Oct 20204:14 pmRNSResult of AGM
14th Oct 20207:00 amRNSTrading Statement
7th Oct 20209:42 amRNSHolding(s) in Company
25th Sep 20202:20 pmRNSAGM arrangements
22nd Sep 20206:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20206:03 pmRNSDirector/PDMR Shareholding
22nd Sep 20208:26 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.